(Q42166125)

17 October 2017

title

Valsartan-induced angioedema (English)

1 reference

17 October 2017

Brian K Irons

1

1 reference

17 October 2017

Ashwani Kumar

series ordinal

2

1 reference

17 October 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

Annals of Pharmacotherapy

17 October 2017

published in

1 reference

17 October 2017

volume

37

1 reference

17 October 2017

issue

7-8

1 reference

17 October 2017

page(s)

1024-1027

1 reference

Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology

17 October 2017

cites work

1 reference

Hypertension and diabetes: new therapeutic options

21 January 2018

1 reference

Clinical profile of angioedema associated with angiotensin converting-enzyme inhibition

21 January 2018

1 reference

Angioneurotic edema attributed to the use of losartan

21 January 2018

1 reference

Losartan-induced angioedema

21 January 2018

1 reference

Angioedema associated with angiotensin II receptor antagonists: challenging our knowledge of angioedema and its etiology.

21 January 2018

1 reference

Angioedema induced by the angiotensin II blocker losartan

21 January 2018

1 reference

Angioedema due to losartan

21 January 2018

1 reference

Angiotensin-converting enzyme inhibition potentiates angiotensin II type 1 receptor effects on renal bradykinin and cGMP.

21 January 2018

1 reference

Angiotensin type 2 receptor mediates valsartan-induced hypotension in conscious rats

21 January 2018

1 reference

A method for estimating the probability of adverse drug reactions

21 January 2018

1 reference

Angioedema associated with candesartan

21 January 2018

1 reference

Angiotensin II receptor blocker-associated angioedema: on the heels of ACE inhibitor angioedema

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1C520

1 reference

17 October 2017

1 reference